{"title":"对“癌症III期非小细胞肺癌治疗专家共识”的澄清","authors":"","doi":"10.1002/med4.25","DOIUrl":null,"url":null,"abstract":"<p>Wu YL, Lu S, Zhou QH, Zhang L, Cheng Y, Wang J, Wang BH, Hu CP, Lin LZ, Zhong WZ, Song Y, Yang N, Dong XR, Zhao J, Yang HH, Guo H, Yan XL, Liu HX, Ma R, Lin J, Liu SY, Chen C, Wang LF, Zhou CZ, Zhou M, Wu F, Yang XN, Du YY, Yao Y, Shao Y, Hong SD, Cui JW, Quan XP, Chen RR, Wu JY, Zhang JT, Zhou JY, Wang BC, Cheng C, Wang HJ, Liu JJ, Wu L, Huang Y, Kuang YK, Zhang YC, Hu J, Yang JJ, Feng WN, Su WM, Fan Y, Yang F, Chen M, Tang KJ, Tang Y, Shen P, Liu AW, Zhang HB, Liang WH, Zhou Q, Ma ZY, Cai XY, Liu H, Chen LF, Chuai SK, Chuai JZ, Zheng YF, You CX, Zhu XX, Li L, Zhang TM, Tu HY, Lin WR, Zhang XC, Zhou PH, Ke ZF, Liang HY. Expert consensus on treatment for stage III non-small cell lung cancer. Med. Adv. 2023;1:3–13.</p><p>We want to clarify that this article was originally published in Chinese in the <i>Journal of Evidence-based Medicine</i> (doi: 10.12019/j.issn.1671-5144.2022.03.001). This is an English translation of the original article and permission was granted by the <i>Journal of Evidence-based Medicine</i>.</p><p>The online version of the original article can be found at http://www.jebm.cn/CN/10.12019/j.issn.1671-5144.2022.03.001.</p>","PeriodicalId":100913,"journal":{"name":"Medicine Advances","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/med4.25","citationCount":"0","resultStr":"{\"title\":\"Clarification to “Expert consensus on treatment for stage III non-small cell lung cancer”\",\"authors\":\"\",\"doi\":\"10.1002/med4.25\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Wu YL, Lu S, Zhou QH, Zhang L, Cheng Y, Wang J, Wang BH, Hu CP, Lin LZ, Zhong WZ, Song Y, Yang N, Dong XR, Zhao J, Yang HH, Guo H, Yan XL, Liu HX, Ma R, Lin J, Liu SY, Chen C, Wang LF, Zhou CZ, Zhou M, Wu F, Yang XN, Du YY, Yao Y, Shao Y, Hong SD, Cui JW, Quan XP, Chen RR, Wu JY, Zhang JT, Zhou JY, Wang BC, Cheng C, Wang HJ, Liu JJ, Wu L, Huang Y, Kuang YK, Zhang YC, Hu J, Yang JJ, Feng WN, Su WM, Fan Y, Yang F, Chen M, Tang KJ, Tang Y, Shen P, Liu AW, Zhang HB, Liang WH, Zhou Q, Ma ZY, Cai XY, Liu H, Chen LF, Chuai SK, Chuai JZ, Zheng YF, You CX, Zhu XX, Li L, Zhang TM, Tu HY, Lin WR, Zhang XC, Zhou PH, Ke ZF, Liang HY. Expert consensus on treatment for stage III non-small cell lung cancer. Med. Adv. 2023;1:3–13.</p><p>We want to clarify that this article was originally published in Chinese in the <i>Journal of Evidence-based Medicine</i> (doi: 10.12019/j.issn.1671-5144.2022.03.001). This is an English translation of the original article and permission was granted by the <i>Journal of Evidence-based Medicine</i>.</p><p>The online version of the original article can be found at http://www.jebm.cn/CN/10.12019/j.issn.1671-5144.2022.03.001.</p>\",\"PeriodicalId\":100913,\"journal\":{\"name\":\"Medicine Advances\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-06-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/med4.25\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medicine Advances\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/med4.25\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicine Advances","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/med4.25","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Clarification to “Expert consensus on treatment for stage III non-small cell lung cancer”
Wu YL, Lu S, Zhou QH, Zhang L, Cheng Y, Wang J, Wang BH, Hu CP, Lin LZ, Zhong WZ, Song Y, Yang N, Dong XR, Zhao J, Yang HH, Guo H, Yan XL, Liu HX, Ma R, Lin J, Liu SY, Chen C, Wang LF, Zhou CZ, Zhou M, Wu F, Yang XN, Du YY, Yao Y, Shao Y, Hong SD, Cui JW, Quan XP, Chen RR, Wu JY, Zhang JT, Zhou JY, Wang BC, Cheng C, Wang HJ, Liu JJ, Wu L, Huang Y, Kuang YK, Zhang YC, Hu J, Yang JJ, Feng WN, Su WM, Fan Y, Yang F, Chen M, Tang KJ, Tang Y, Shen P, Liu AW, Zhang HB, Liang WH, Zhou Q, Ma ZY, Cai XY, Liu H, Chen LF, Chuai SK, Chuai JZ, Zheng YF, You CX, Zhu XX, Li L, Zhang TM, Tu HY, Lin WR, Zhang XC, Zhou PH, Ke ZF, Liang HY. Expert consensus on treatment for stage III non-small cell lung cancer. Med. Adv. 2023;1:3–13.
We want to clarify that this article was originally published in Chinese in the Journal of Evidence-based Medicine (doi: 10.12019/j.issn.1671-5144.2022.03.001). This is an English translation of the original article and permission was granted by the Journal of Evidence-based Medicine.
The online version of the original article can be found at http://www.jebm.cn/CN/10.12019/j.issn.1671-5144.2022.03.001.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
